Home › Funds › Blue Owl Capital Holdings LP › CNTX

Blue Owl Capital Holdings LP position in CNTX

CONTEXT THERAPEUTICS INC · Health Care

Blue Owl Capital Holdings LP reported holding 2,934,015 shares of CNTX (CONTEXT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.6M, representing 0.26% of its reported portfolio and ranking #30 among its reported holdings. Blue Owl Capital Holdings LP has disclosed CNTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)2.93M sh
Reported value held$1.63M
Portfolio Weight0.26%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Blue Owl Capital Holdings LP's CNTX position evolved

Blue Owl Capital Holdings LP first disclosed a stake in CNTX in Q2 2024 at 5,161,290 shares (US$10.3M). The position peaked in Q1 2026 at 5,089,015 shares, worth US$13.3M. Across 9 filings, Blue Owl Capital Holdings LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,934,015 shares valued at US$1.6M — a reduction of -2,155,000 shares quarter over quarter.. Notable position changes include a 32% trim in Q1 2026 (shares fell 79% over the following quarter), a 42% trim in Q2 2026 (shares fell 46% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 5.16M $10.35M New
Q3 2024 5.41M $10.61M Add
Q4 2024 6.36M $6.68M Add
Q1 2025 7.37M $4.51M Add
Q2 2025 7.41M $4.85M Add
Q3 2025 7.41M $7.18M Hold
Q4 2025 7.43M $10.93M Hold
Q1 2026 5.09M $13.33M Reduce
Q2 2026 2.93M $1.63M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CNTX and 13F data

CNTX (CONTEXT THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in CNTX — the largest reported positions include Nextech Invest Ltd. (US$4.1M), Avidity Partners Management LP (US$2.8M), Octagon Capital Advisors LP (US$1.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CNTX

All CNTX fund holders →

FAQ

How long has Blue Owl Capital Holdings LP held CNTX?

Blue Owl Capital Holdings LP has disclosed CNTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is Blue Owl Capital Holdings LP's current position in CNTX?

As of Q2 2026, Blue Owl Capital Holdings LP holds 2.93M shares of CNTX (CONTEXT THERAPEUTICS INC), valued at $1.63M, representing 0.26% of its reported portfolio and ranking #30.

Has Blue Owl Capital Holdings LP been buying or selling CNTX?

In the latest 13F filing (Q2 2026), Blue Owl Capital Holdings LP reduced its position in CNTX. The position peaked in Q1 2026 at 5.09M shares.

Which other funds hold CNTX?

Other major institutional holders of CNTX include Nextech Invest Ltd., Avidity Partners Management LP, Octagon Capital Advisors LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.